Wegovy Reduces BMI in Kids With Obesity as Young as 6 | HappeningNow.news

Health · 3 views

Wegovy Reduces BMI in Kids With Obesity as Young as 6

Source Summary Published 1h 27m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 3 Community interest
Brief read Under 1 min brief 35 words

Summary

(MedPage Today) -- NATIONAL HARBOR, Md. -- Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase III STEP Young trial.

Read original at MedPage Today

Coverage Context

Part of BMI coverage 28 tracked stories

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page